CANDIDO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 7.613
AS - Asia 5.933
EU - Europa 3.971
SA - Sud America 867
AF - Africa 186
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 14
Totale 18.623
Nazione #
US - Stati Uniti d'America 7.429
SG - Singapore 2.017
CN - Cina 1.293
IT - Italia 786
HK - Hong Kong 724
PL - Polonia 712
BR - Brasile 630
KR - Corea 551
VN - Vietnam 535
SE - Svezia 419
UA - Ucraina 311
FR - Francia 297
FI - Finlandia 264
DE - Germania 237
GB - Regno Unito 222
NL - Olanda 183
IN - India 167
RU - Federazione Russa 165
TR - Turchia 136
MX - Messico 86
BG - Bulgaria 73
MA - Marocco 71
AR - Argentina 67
JP - Giappone 63
IE - Irlanda 62
CA - Canada 59
BD - Bangladesh 56
ID - Indonesia 54
ES - Italia 53
CO - Colombia 42
PK - Pakistan 42
AT - Austria 38
EC - Ecuador 38
PH - Filippine 35
IQ - Iraq 34
TW - Taiwan 31
AU - Australia 30
PE - Perù 29
ZA - Sudafrica 28
EG - Egitto 24
BE - Belgio 23
CH - Svizzera 20
CL - Cile 20
SA - Arabia Saudita 20
IR - Iran 18
TH - Thailandia 18
IL - Israele 17
HR - Croazia 16
TN - Tunisia 16
CZ - Repubblica Ceca 15
PY - Paraguay 15
VE - Venezuela 15
SN - Senegal 14
AZ - Azerbaigian 13
LB - Libano 13
NP - Nepal 13
JO - Giordania 12
UZ - Uzbekistan 12
GR - Grecia 11
MY - Malesia 10
EU - Europa 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
DK - Danimarca 8
NZ - Nuova Zelanda 8
RS - Serbia 8
KE - Kenya 7
KZ - Kazakistan 7
PT - Portogallo 7
AL - Albania 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
LT - Lituania 6
NI - Nicaragua 6
RO - Romania 6
CY - Cipro 5
UY - Uruguay 5
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
LU - Lussemburgo 4
PA - Panama 4
PS - Palestinian Territory 4
AM - Armenia 3
HN - Honduras 3
LK - Sri Lanka 3
LV - Lettonia 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
Totale 18.588
Città #
Singapore 1.160
Ashburn 728
Hong Kong 712
Woodbridge 700
Ann Arbor 624
Warsaw 593
Houston 580
San Jose 542
Fairfield 527
Seoul 524
Chandler 411
Hefei 360
Boardman 294
Seattle 263
Jacksonville 259
Beijing 247
Wilmington 244
Ho Chi Minh City 183
Cambridge 176
Helsinki 139
Trieste 132
Chicago 127
Hanoi 124
Los Angeles 117
Lauterbourg 99
Princeton 98
Zgierz 98
The Dalles 93
Izmir 90
Columbus 86
Moscow 77
Milan 73
London 71
Frankfurt am Main 69
Council Bluffs 68
Dallas 65
Casablanca 63
São Paulo 63
Sofia 62
Dublin 58
Santa Clara 55
Buffalo 50
New York 46
Rome 42
Tokyo 42
Düsseldorf 41
Shanghai 41
Dearborn 40
Nuremberg 39
Munich 37
Chennai 30
San Diego 30
Orem 26
Mumbai 25
Brussels 23
Jinan 23
Guangzhou 22
Boston 21
Haiphong 21
Zhengzhou 21
Atlanta 20
Phoenix 20
Brooklyn 19
Hangzhou 19
Redondo Beach 19
Rio de Janeiro 19
Chengdu 18
Da Nang 18
Dhaka 18
Lappeenranta 18
Manchester 18
Stockholm 18
Turku 18
Baghdad 17
Montreal 17
Vienna 17
Washington 17
Cairo 16
Denver 15
Istanbul 15
Mexico City 15
Verona 15
Amsterdam 14
Bari 14
Johannesburg 14
Karachi 14
Quito 14
Tianjin 14
Ankara 13
Dakar 13
Falls Church 13
Jakarta 13
Santiago 13
Segrate 13
Venice 13
Amman 12
Baku 12
Belo Horizonte 12
Bogotá 12
Guayaquil 12
Totale 12.295
Nome #
A new ultrasonographic instrument for measuring vessel wall shear stress. 467
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 410
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 402
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 337
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events 329
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 315
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 294
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 293
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 268
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. 263
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 263
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 255
DOSE AND TIME-DEPENDENT APOPTOTIC EFFECTS BY ANGIOTENSIN II INFUSION ON LEFT VENTRICULAR CARDIOMYOCYTES. 253
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 246
ACE2 deficiency shifts energy metabolism towards glucose utilization 238
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 233
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 222
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 220
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 217
TRAIL shows potential cardioprotective activity. 215
Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm 215
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 214
Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials 213
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 212
Haemoconcentration, shear-stress elevation and carotid artery diameter regulation after furosemide in older hypertensives 205
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 203
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 201
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 200
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 199
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension 195
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 190
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 181
Comparative effects of antihypertensive and/or antioxidative treatment in an experimental model of chronic progressive nephrosis 178
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB 178
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 177
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 173
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 173
Endothelial dysfunction (ED) in familial hypercholesterolemia (FH). Role of the LDL-cholesterol (LDL) variations after LDL-aphaeresis (LDL-A) vs medical therapy 171
Angiotensin II promotes apoptosis in ventricular cardiomyoctes in vivo 171
Modulation of cardiac apoptosis by estrogen and ACE inhibition in ovariectomized spontaneously hypertensive rats 165
In vivo effects of fluvastatin on leukocyte vascular trafficking under experimental acute inflammatory conditions 160
Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: a retrospective cohort study 158
Hypertension and diabetes: emphasis on the renin-angiotensin system in atherosclerosis 155
Regional and systemic haemodynamic response to aortography in hypertensives. 152
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 151
Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group 150
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 147
Linking diabetes and atherosclerosis 146
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents 146
Italian guidelines for the treatment of type 2 diabetes 144
Endothelium vasomotor function after LDL-apheresis in patients with familial hypercolesterolemia 138
Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression 135
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials. 132
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 132
Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells 129
Treatment for diabetic nephropathy - a review of the recent patent literature 125
Forearm endothelial dysfuncion (ED) is a marker of the epato-renal vascular impairment but not of the systemic haemodynamic control in cirrhotic patients 123
Retrospective cohort study on treatment outcomes of early vs late onset gestational diabetes mellitus 121
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive doses of an ACE inhibitor 120
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience 119
Personalized Approach for the Management of Exercise-Related Glycemic Imbalances in Type 1 Diabetes: Comparison with Reference Method 119
Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years 118
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice 117
Large artery mechanics after bladder neck obstruction in SHR rats 117
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 115
A review of the latest real‐world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions? 114
Safety and Appropriateness in the Management of the Treatment Pathway of Pregnant Women with Gestational Diabetes 113
Modulation of glomerular albumin permeability by angiotensin II infusion and effects of angiotensin type 1 receptor blockade 113
A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy 105
2023 update on Italian guidelines for the treatment of type 2 diabetes 101
The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals initiative 99
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 98
La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti 95
ACE-inhibitor treatment prevents cardiac remodelling in experimental uremia 94
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 94
The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care 93
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products 92
Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes 92
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study 91
Ace Inhibitor treatment prevents renal growth and hyperfiltration in streptozotocin diabetic rats 90
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes 89
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 87
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 86
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database 86
Sinergia collaborativa nella gestione del paziente diabetico con recente sindrome coronarica acuta 85
Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform 84
Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative 84
Prevalence and clinical determinants of rapid eGFR decline among patients with newly diagnosed type 2 diabetes 82
ACE inhibitor treatment prevents cardiac programmed cell death and intermyocardiocytic fibrosis in hypertensive diabetic rats 81
Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications 79
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies 78
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies 77
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study 77
A new ultrasonographic instrument for measuring vessel wall shear stress: Comparison to a mathematical model in essential hypertensives 77
Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk 73
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey 73
Clinical Inertia Is the Enemy of Therapeutic Success in the Management of Diabetes and Its Complications: A Narrative Literature Review 72
When does metabolic memory start? Insights from the AMD Annals Initiative on stringent HbA1c targets 72
Generalizability of kidney and cardiovascular protection by finerenone to the real world in Italy: insights from Fidelio and Figaro studies 71
Socioeconomic and health disparities in adults diagnosed with type 1 diabetes mellitus before age 18: insights from the Italian PASSI surveillance system 71
Totale 15.991
Categoria #
all - tutte 55.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 0 0 0 0 116 34 79
2021/2022631 24 36 24 58 21 57 32 17 71 67 54 170
2022/20231.120 87 126 99 146 113 207 3 108 155 15 46 15
2023/20241.332 47 233 74 57 109 86 201 148 23 27 157 170
2024/20253.585 128 125 206 240 527 464 305 203 389 434 261 303
2025/20267.362 636 568 570 839 610 704 1.010 363 984 1.078 0 0
Totale 19.068